Inventor · disambiguated record
Fabio Montrasio
Also filed as: MONTRASIO FABIO
10 granted patents·8 pending applications·43 citations·filing 2011–2024
87Inventor score
Files withNEURIMMUNE HOLDING AG7BIOGEN MA INC5BIOGEN INT NEUROSCIENCE GMBH3MONTRASIO FABIO1NEURIMMUNE AG1
Top patents by PatentIndex Score
18 records- 0193US9598484B2Human anti-tau antibodiesBIOGEN MA INC·Filed 2013·Granted Mar 21, 2017·18 cites·182 claims
- 0287US10961322B2Human-derived anti-dipeptide repeats (DPRs) antibodyNEURIMMUNE HOLDING AG·Filed 2019·Granted Mar 30, 2021·2 cites·27 claims
- 0386US10259866B2TDP-43 specific binding moleculesBIOGEN INT NEUROSCIENCE GMBH·Filed 2016·Granted Apr 16, 2019·7 cites·88 claims
- 0485US2024254256A1Human Anti-SOD1 AntibodiesNEURIMMUNE HOLDING AG·Filed 2024·Application pending·0 cites
- 0584US9587014B2TDP-43 specific binding moleculesBIOGEN INT NEUROSCIENCE GMBH·Filed 2012·Granted Mar 7, 2017·7 cites·33 claims
- 0682US2024279361A1Human-derived anti-dipeptide repeats (dprs) antibodyNEURIMMUNE HOLDING AG·Filed 2023·Application pending·0 cites
- 0779US9283271B2Human anti-SOD1 antibodiesMONTRASIO FABIO·Filed 2011·Granted Mar 15, 2016·5 cites·21 claims
- 0878US10392447B2Human-derived anti-dipeptide repeats (DPRs) antibodyNEURIMMUNE HOLDING AG·Filed 2015·Granted Aug 27, 2019·2 cites·120 claims
- 0977US2022267471A1Human Anti-SOD1 AntibodiesNEURIMMUNE HOLDING AG·Filed 2022·Application pending·0 cites
- 1073US12162952B2Human-derived anti-(poly-GA) dipeptide repeat (DPR) antibodyBIOGEN MA INC·Filed 2019·Granted Dec 10, 2024·1 cites·18 claims
- 1172US2020262895A1Human anti-tau antibodiesBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 1271US11352441B2Human anti-SOD1 antibodiesNEURIMMUNE HOLDING AG·Filed 2019·Granted Jun 7, 2022·0 cites·14 claims
- 1371US10344097B2Human anti-SOD1 antibodiesNEURIMMUNE HOLDING AG·Filed 2016·Granted Jul 9, 2019·1 cites·11 claims
- 1469US11091540B2TDP-43 specific binding moleculesBIOGEN INT NEUROSCIENCE GMBH·Filed 2019·Granted Aug 17, 2021·0 cites·31 claims
- 1559US2019169274A1Human anti-tau antibodiesBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 1658US2024101654A1Human anti-tau antibodiesNEURIMMUNE AG·Filed 2021·Application pending·0 cites
- 1756US2024309076A1Tau-specific antibody gene therapy compositions, methods and uses thereofREGENXBIO INC·Filed 2021·Application pending·0 cites
- 1855US2017369560A1Human anti-tau antibodiesBIOGEN MA INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fabio Montrasio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →